Efficacy and Safety of Immunotherapies in Refractory Myasthenia Gravis: A Systematic Review and Meta-Analysis

Introduction: Approximately 10–20% of patients WITH myasthenia gravis (MG) are refractory to conventional immunotherapies. The purpose of this study was to conduct a systematic review and meta-analysis to explore the optimal therapies for refractory MG. Method: Correlative studies were performed thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xuelin, Song, Zubiao, Wu, Mengli, Liu, Yanmei, Luo, Sushan, Zhao, Chongbo, Zhang, Weixi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672452/
https://www.ncbi.nlm.nih.gov/pubmed/34925206
http://dx.doi.org/10.3389/fneur.2021.725700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672452/
https://www.ncbi.nlm.nih.gov/pubmed/34925206
http://dx.doi.org/10.3389/fneur.2021.725700

Ejemplares similares